Tissue Tek O.C.T. Compound
To Order Now: info@anbioq.org
 Compound 401 |
|||
| B7337-25 | ApexBio | 25 mg | EUR 441 |
Compound 401 |
|||
| B7337-5 | ApexBio | 5 mg | EUR 180 |
 Compound CL0485 |
|||
| ADC-P-074 | Creative Biolabs | unit | Ask for price |
Compound 401 |
|||
| HY-19341 | MedChemExpress | 10mM/1mL | EUR 186 |
 Compound E |
|||
| HY-14176 | MedChemExpress | 10mM/1mL | EUR 694 |
 Compound 34 |
|||
| GL2080-1MG | Glentham Life Sciences | 1 mg | EUR 373 |
Compound 34 |
|||
| GL2080-200UG | Glentham Life Sciences | 200 ug | EUR 166 |
 Compound 112254 |
|||
| GL3740-10MG | Glentham Life Sciences | 10 mg | EUR 166 |
Compound 112254 |
|||
| GL3740-50MG | Glentham Life Sciences | 50 mg | EUR 459 |
Compound E |
|||
| GL3746-1MG | Glentham Life Sciences | 1 mg | EUR 378 |
Compound E |
|||
| GL3746-250UG | Glentham Life Sciences | 250 ug | EUR 172 |
Compound E |
|||
| GL3746-5MG | Glentham Life Sciences | 5 mg | EUR 998 |
 Compound 2 |
|||
| HY-U00358 | MedChemExpress | 10mg | EUR 6041 |
 Compound W |
|||
| A4401-50 | ApexBio | 50 mg | EUR 177 |
|
Description: Inhibitor of ?-secretase; causes a decrease in the released levels of A?42 and notch-1 A?-like peptide 25 (N?25). |
|||
 Compound 56 |
|||
| A8197-.5 | ApexBio | 500 µg | EUR 108 |
|
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM. |
|||
Compound 56 |
|||
| A8197-5 | ApexBio | 5 mg | EUR 224 |
|
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM. |
|||
Compound 56 |
|||
| A8197-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 270 |
|
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM. |
|||
Compound 56 |
|||
| A8197-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM. |
|||
Compound 401 |
|||
| 1657-5 | Biovision | EUR 238 | |
 Compound 1 |
|||
| 1688-5 | Biovision | EUR 207 | |
Compound 34 |
|||
| 1898-1000 | Biovision | EUR 457 | |
Compound 34 |
|||
| 1898-200 | Biovision | EUR 158 | |
Compound E |
|||
| 1949-1000 | Biovision | EUR 370 | |
Compound E |
|||
| 1949-250 | Biovision | EUR 153 | |
Compound W |
|||
| 2208-250 | Biovision | EUR 300 | |
Compound W |
|||
| 2208-50 | Biovision | EUR 115 | |
Compound 112254 |
|||
| 2573-25 | Biovision | EUR 588 | |
Compound 112254 |
|||
| 2573-5 | Biovision | EUR 185 | |
 Compound K |
|||
| N1890-20 | ApexBio | 20 mg | EUR 340 |
|
Description: Compound K |
|||
 Imidazoquinoline Compound |
|||
| VAdv-Ly0028 | Creative Biolabs | 5 mg | EUR 3280 |
|
Description: Imidazoquinoline compound, a TLR7 agonist vaccine adjuvant. |
|||
 TEK siRNA |
|||
| 20-abx936459 | Abbexa |
|
|
|
|||